During the past decade, CH d'Alès conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH d'Alès" #1 sponsor was "Centre Hospitalier Universitaire de Nīmes" with 11 trials, followed by "Hospira, now a wholly owned subsidiary of Pfizer" with 2 trials sponsored, "Assistance Publique - Hôpitaux de Paris" with 1 trials sponsored, "Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète" with 1 trials sponsored and "LivaNova" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH d'Alès" #1 collaborator was "University Hospital, Montpellier" with 2 trials as a collaborator, "CENTRE HOSPITALIER COMMINGES PYRENEES" with 1 trials as a collaborator, "CH Bagnols sur Cèze" with 1 trials as a collaborator, "CH Béziers" with 1 trials as a collaborator and "CH Narbonne HÔTEL DIEU" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "CH d'Alès" are "Acute Kidney Injury" (1 trials), "Acute Renal Colic" (1 trials), "Cancer" (1 trials), "Carcinoma, Squamous Cell" (1 trials) and "Chemotherapy-induced Anemia" (1 trials). Many other conditions were trialed in "CH d'Alès" in a lesser frequency.

Most popular intervention types in "CH d'Alès" are "Other" (6 trials), "Procedure" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "DIABEO software" (1 trials), "Definition of the Individualized Care Pathway" (1 trials), "Delayed strategy" (1 trials), "Dietary advice sheet" (1 trials) and "Geriatric evaluation" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH d'Alès" are 17 trials for "All" genders.

Currently, there are NaN active trials in "CH d'Alès". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in CH d'Alès, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CH d'Alès, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".